Search

everythinglearnresearchcommunity

for

Search:↓

Blocking enzymes that help the virus enter cells could be a promising way to treat COVID-19.

Some cases of tinea capitis, a fungal scalp infection, can look like scarring hair loss due to the body's immune response and the fungus itself.

The conclusion is that proper recognition and treatment of skin conditions are crucial for the elderly due to changes in skin, nails, and hair with age, and the impact of these conditions on health and mobility.

PLAU and SerpinB2 affect cell death differently in various forms of leprosy and could be targets for new treatments.

Knowing how skin works and its diseases helps doctors diagnose and treat skin conditions better.

Scientists successfully created and transplanted bioengineered hair follicles that function like natural ones, suggesting a new treatment for hair loss.

Understanding how our bodies interact with mosquito-borne viruses is crucial because there are few treatments and vaccines.

Host cells are crucial for the maturation of reconstructed hair follicles.

Certain genes and nutrients like vitamin D, zinc, and omega fatty acids affect COVID-19 severity and infection risk.

Leprosy is mainly contracted during infancy or childhood.

Existing drugs, including a blood pressure medication, show promise as new treatments for influenza.

The symposium concluded that environmental factors significantly contribute to skin aging.

Tribuloside can increase skin pigmentation by enhancing melanin production and distribution.

Some early COVID-19 mutations in patients predicted future common virus mutations.

A Japanese bone marrow transplant patient developed a rare skin cancer possibly linked to long-term use of the medication voriconazole.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

Permanent hair loss after a stem cell transplant can be a sign of chronic immune system attack on the scalp.

CD8+ T cells play a key role in graft-versus-host disease in certain mice models.

Ruxolitinib helps protect skin stem cells and keeps skin healthy in mice with skin GVHD.

Ruxolitinib may help treat hair loss and symptoms in patients with chronic graft-versus-host disease.

A 65-year-old man developed a serious skin cancer linked to a drug he was taking for a fungal infection after a bone marrow transplant.

Patients with graft-versus-host disease often have nail changes related to the nail matrix, with severity not linked to skin condition.

Umbilical cord blood transplantation improved the boy's symptoms despite complications.

People with allergies or high eosinophil levels have a higher chance of severe hair loss from alopecia areata, and sudden hair loss can indicate chronic graft-versus-host disease.

Skin problems are common after stem cell transplants, and early treatment by dermatologists can improve patient outcomes.

Exosome-enriched vesicles from placental cells improved skin condition in a patient with chronic graft-versus-host disease.

Some children who had stem cell transplants developed permanent hair loss, especially when treated with a drug called busulphan.

A woman with thymoma developed a rare chronic condition similar to graft versus host disease after surgery.

ATIR101 improves survival in stem cell transplant patients; Australian stem cell treatment decisions are influenced by regulation changes.

Patients often experience long-lasting changes to their hair after stem cell transplants.